Intuitive Surgical: FY26 Q3 earnings call, Oct 20, 2026
On its Oct 20, 2026 earnings call (FY26 Q3), Intuitive Surgical said 11 of the 14 words Kalshi listed; Parrot’s count agreed with all 14 settlements. Quotes below are at most 25 words each, with timed clips.
UpdatedMarkets
14 words · 11 settled yes · our count agreed on 14 of 14- Kalshi: company speakers + operator
Kalshi
backtest The probabilities on settled rows are a walk-forward backtest: the model as of before each event, computed after Parrot went live; they were not published at the time.
| Word | Result | Our count | All speakers | Agrees | Probability | Clip | Market |
|---|---|---|---|---|---|---|---|
| Da Vinci 5 3+ times | Yes | 30 | 30 | ✓ | 88%transcripts from the transcript model | Hear it 4:04, Da Vinci 5 (3+ times) | – |
| Ion 3+ times | Yes | 17 | 17 | ✓ | 90%transcripts from the transcript model | Hear it 2:16, Ion (3+ times) | – |
| China | Yes | 7 | 8 | ✓ | 90%transcripts from the transcript model | Hear it 7:10, China | – |
| Reimbursement | Yes | 5 | 5 | ✓ | 86%transcripts from the transcript model | Hear it 6:32, Reimbursement | – |
| Hernia | Yes | 5 | 5 | ✓ | 79%transcripts from the transcript model | Hear it 6:21, Hernia | – |
| Tariff | Yes | 4 | 4 | ✓ | 85%transcripts from the transcript model | Hear it 12:59, Tariff | – |
| FDA | Yes | 4 | 4 | ✓ | 70%transcripts from the transcript model | Hear it 8:11, FDA | – |
| International | Yes | 3 | 3 | ✓ | 82%transcripts from the transcript model | Hear it 6:04, International | – |
| Telepresence | Yes | 2 | 2 | ✓ | 65%transcripts from the transcript model | Hear it 9:10, Telepresence | – |
| Medicare / Medicaid | Yes | 1 | 1 | ✓ | 59%transcripts from the transcript model | Hear it 15:49, Medicare / Medicaid | – |
| Autonomy | Yes | 1 | 1 | ✓ | 39%transcripts from the transcript model | Hear it 8:21, Autonomy | – |
| Acquire / Acquired / Acquisition | No | 0 | 0 | ✓ | 73%transcripts from the transcript model | – | |
| Supply Chain | No | 0 | 0 | ✓ | 58%transcripts from the transcript model | – | |
| GLP-1 | No | 0 | 0 | ✓ | 57%transcripts from the transcript model | – |
Market prices are mid quotes from Kalshi and Polymarket, shown for context, may be delayed by several minutes and are not a signal. Quotes as of Oct 21, 2026 13:45 UTC.
Transcript
quotes of at most 25 wordsSpeaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.
5 matches for “Hernia”; 5 quoted, at least 25 words apart.
…hysterectomy in Germany, colon cystectomy in the U.K. and India, and inguinal hernia repair in Japan. To support this growth, we are continuing to build…
…37% in Q2 and 34% in Q1, with the strongest growth in hernia repair and cholecystectomy. Benign procedures represent over a quarter of our international…
…and clinical capability. In high-volume benign procedures such as cholecystectomy and inguinal hernia repair, it comes from reliability, efficiency, and economics, and that's where our…
…including but not limited to benign hysterectomy, cholecystectomy, benign colon, and various hernia repairs. In many of these procedures, conventional laparoscopy has long been the…
…of conversion, with significant reductions observed in benign hysterectomy, ventral and inguinal hernia repair, myomectomy, cholecystectomy, and benign colon surgery. As the authors noted,…
Where the listed words were said
da Vinci system placements increased 28% worldwide, with da Vinci 5 and SP accounting for 65% of global placements. Installations of XiR and X more…
…quarter for Intuitive, with broad-based adoption across our multi-port, single port, and Ion platforms. In Q3, total procedures increased 15%, driven by 14% growth in…
…quarter with 42% procedure growth, surpassing 200,000 cumulative da Vinci procedures. In China, the operating environment remains challenging. To support expected long-term growth in Asia,…
…time between detection and treatment of lung cancer. During Q3, we received reimbursement for Ion in Korea, and we expect further reimbursement actions in other…
…operating margin was 42% of revenue, or 41% excluding a one-time pre-tax tariff refund of $28 million. Non-GAAP earnings per share grew 25% to $3…
…in the U.S., Europe, India, Japan, and Korea. During Q3, we received FDA 510(k) clearance on da Vinci 5 for surgeon-initiated tool eject and multi-arm…
Adoption of Intuitive Telepresence continues to increase, with surgeons using these sessions to share techniques and to scale training in ways that were not previously…
…we continue to monitor the impacts from lower ACA enrollment, changes to Medicaid eligibility, and potential changes to 340B. Outside the U.S., total and da…
Agents: this page as TSV at /api/v1/appearances/intuitive-surgical:2026-10-20:earnings_call · words: /api/v1/brief?appearance=intuitive-surgical:2026-10-20:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP